SGMO 241220 1.50C (SGMO241220C1500) Stock Options, News & Quotes

0.90
+0.10+12.50%

15min DelayClose Dec 20 16:00 ET

1.03High0.90Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

BigAlMoney

Dec 20 16:48

Fabry deal still in the works

$Sangamo Therapeutics (SGMO.US)$
Should be interesting to see what we get in up front. It's been given Accelerated Approval by FDA so BLA will be filed next year sometime once we get final patient data. I'm guessing 100 to 200 million up front.

Teddy123

Dec 20 15:03

Hello. How about u aim for that $10 target

$Sangamo Therapeutics (SGMO.US)$

Wekang

Dec 20 01:50

$Sangamo Therapeutics (SGMO.US)$ lets see how it goes. W pattern maybe.

Toninho Sandro

Dec 20 00:57

$Sangamo Therapeutics (SGMO.US)$ net outflow, rid off weak holders, yet price holding up well. in the watch list for dip picking.

Teddy123

Dec 19 12:39

Positive biotech research insights

$Sangamo Therapeutics (SGMO.US)$
The STAC-BBB capsid technology addresses one of gene therapy's most challenging obstacles - crossing the blood-brain barrier efficiently. Traditional AAV vectors struggle with CNS penetration, often requiring invasive direct administration. An effective IV-delivered solution could revolutionize neurological gene therapy by enabling broader distribution and simplified administration.
The non-human primate data showing potent BBB ...